Stay updated on GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice announces an NIH-wide transition in terminology, saying agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:39:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T15:35:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:47:08.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with a minimal header and a Home link, indicating the study record is currently inaccessible. The substantive study content that was previously visible appears removed or blocked.
    Difference
    19%
    Check dated 2026-09-20T19:49:17.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T08:41:16.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page previously showing an error has been updated to display the complete study record for NCT03161379. The new content includes study overview, conditions, interventions, outcomes, enrollment and locations, investigators, and links to related documents.
    Difference
    55%
    Check dated 2026-08-16T01:48:37.000Z thumbnail image

Stay in the know with updates to GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX Vaccine + Nivolumab and SBRT in Pancreatic Cancer Clinical Trial page.